Details of the Drug

General Information of Drug (ID: DM96AKV)

Drug Name

PF-06747775

Synonyms

mavelertinib; JYIUNVOCEFIUIU-RRKGBCIJSA-N; PF06747775; SCHEMBL20274518; BCP17532

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C18H22FN9O2
Canonical SMILES: CN1C=C(C(=N1)OC)NC2=C3C(=NC(=N2)N4CC(C(C4)F)NC(=O)C=C)N(C=N3)C
InChI: 1S/C18H22FN9O2/c1-5-13(29)21-11-8-28(6-10(11)19)18-23-15(14-16(24-18)26(2)9-20-14)22-12-7-27(3)25-17(12)30-4/h5,7,9-11H,1,6,8H2,2-4H3,(H,21,29)(H,22,23,24)/t10-,11-/m1/s1
InChIKey: JYIUNVOCEFIUIU-GHMZBOCLSA-N

Cross-matching ID

Combinatorial Drugs (CBD)

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)